Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 90 | ECE2023 | Next issue

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

Card image cap
ECE 2023 will be held in Istanbul, Turkey from 13-16 May 2023. Istanbul is known for its rich culture, historical sites and dynamic nightlife, and we are excited to come together in this city, and look forward to meeting old friends, making new ones, and sharing science, collaborations and ideas.

Joint Sessions

Joint Session 5: ESE, SBEM, FASEN and SMNE

ea0090js5.1 | Joint Session 5: ESE, SBEM, FASEN and SMNE | ECE2023

Obesity and metabolic syndrome in Type 1 Diabetes

Faradji Raquel N

In recent years there has been an increase in the incidence and prevalence of overweight and obesity around the world. Overweight and obesity are more common among people living with type 1 diabetes (T1D) than originally anticipated1 . The SEARCH study found 21% of T1D patients are overweight2 and 12.6%3 are obese. The T1D Exchange Study found an obesity rate of 13.1% in adolescents4 . The DCCT-EDIC Study found that the obesity preva...

ea0090js5.2 | Joint Session 5: ESE, SBEM, FASEN and SMNE | ECE2023

Testosterone replacement in metabolic disorders. To give or not to give

Knoblovits Pablo

Several studies have shown that men with obesity, insulin resistance, prediabetes, and type 2 diabetes mellitus (DM2) have significantly lower testosterone (T) levels and a higher prevalence of hypogonadism than men with normal metabolic status. It is estimated that between 30 and 40% of men with T2DM have low levels of T, assessed as total T, free T, or bioavailable T. But, as part of the integrative metabolic system, testosterone has insulin-sensitizing hormone properties th...